These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

164 related items for PubMed ID: 38492126

  • 1. The changes of oxygen extraction fraction in different types of lesions in relapsing-remitting multiple sclerosis: A cross-sectional and longitudinal study.
    Xie Y, Zhang S, Wu D, Yao Y, Cho J, Lu J, Zhu H, Wang Y, Zhang Y, Zhu W.
    Neurol Sci; 2024 Aug; 45(8):3939-3949. PubMed ID: 38492126
    [Abstract] [Full Text] [Related]

  • 2. MR Susceptibility Separation for Quantifying Lesion Paramagnetic and Diamagnetic Evolution in Relapsing-Remitting Multiple Sclerosis.
    Zhu Z, Naji N, Esfahani JH, Snyder J, Seres P, Emery DJ, Noga M, Blevins G, Smyth P, Wilman AH.
    J Magn Reson Imaging; 2024 Nov; 60(5):1867-1879. PubMed ID: 38308397
    [Abstract] [Full Text] [Related]

  • 3. Quantitative susceptibility mapping of both ring and non-ring white matter lesions in relapsing remitting multiple sclerosis.
    Coffman CH, White R, Subramanian K, Buch S, Bernitsas E, Haacke EM.
    Magn Reson Imaging; 2022 Sep; 91():45-51. PubMed ID: 35605736
    [Abstract] [Full Text] [Related]

  • 4. Brain oxygen extraction fraction mapping in patients with multiple sclerosis.
    Cho J, Nguyen TD, Huang W, Sweeney EM, Luo X, Kovanlikaya I, Zhang S, Gillen KM, Spincemaille P, Gupta A, Gauthier SA, Wang Y.
    J Cereb Blood Flow Metab; 2022 Feb; 42(2):338-348. PubMed ID: 34558996
    [Abstract] [Full Text] [Related]

  • 5. Cortical and Subcortical Morphometric and Iron Changes in Relapsing-Remitting Multiple Sclerosis and Their Association with White Matter T2 Lesion Load : A 3-Tesla Magnetic Resonance Imaging Study.
    Al-Radaideh A, Athamneh I, Alabadi H, Hbahbih M.
    Clin Neuroradiol; 2019 Mar; 29(1):51-64. PubMed ID: 29299614
    [Abstract] [Full Text] [Related]

  • 6. Quantitative T1 brain mapping in early relapsing-remitting multiple sclerosis: longitudinal changes, lesion heterogeneity and disability.
    Harper JG, York EN, Meijboom R, Kampaite A, Thrippleton MJ, Kearns PKA, Valdés Hernández MDC, Chandran S, Waldman AD, FutureMS consortium.
    Eur Radiol; 2024 Jun; 34(6):3826-3839. PubMed ID: 37943312
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Quantitative susceptibility mapping identifies inflammation in a subset of chronic multiple sclerosis lesions.
    Kaunzner UW, Kang Y, Zhang S, Morris E, Yao Y, Pandya S, Hurtado Rua SM, Park C, Gillen KM, Nguyen TD, Wang Y, Pitt D, Gauthier SA.
    Brain; 2019 Jan 01; 142(1):133-145. PubMed ID: 30561514
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Quantitative Susceptibility Mapping of Time-Dependent Susceptibility Changes in Multiple Sclerosis Lesions.
    Zhang S, Nguyen TD, Hurtado Rúa SM, Kaunzner UW, Pandya S, Kovanlikaya I, Spincemaille P, Wang Y, Gauthier SA.
    AJNR Am J Neuroradiol; 2019 Jun 01; 40(6):987-993. PubMed ID: 31097429
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. A New Advanced MRI Biomarker for Remyelinated Lesions in Multiple Sclerosis.
    Rahmanzadeh R, Galbusera R, Lu PJ, Bahn E, Weigel M, Barakovic M, Franz J, Nguyen TD, Spincemaille P, Schiavi S, Daducci A, La Rosa F, Absinta M, Sati P, Bach Cuadra M, Radue EW, Leppert D, Kuhle J, Kappos L, Brück W, Reich DS, Stadelmann C, Wang Y, Granziera C.
    Ann Neurol; 2022 Sep 01; 92(3):486-502. PubMed ID: 35713309
    [Abstract] [Full Text] [Related]

  • 16. Diffusely abnormal white matter converts to T2 lesion volume in the absence of MRI-detectable acute inflammation.
    Dadar M, Mahmoud S, Narayanan S, Collins DL, Arnold DL, Maranzano J.
    Brain; 2022 Jun 30; 145(6):2008-2017. PubMed ID: 34927199
    [Abstract] [Full Text] [Related]

  • 17. Deeply 3D-T1-TFE hypointense voxels are characteristic of phase-rim lesions in multiple sclerosis.
    Naval-Baudin P, Pons-Escoda A, Camins À, Arroyo P, Viveros M, Castell J, Cos M, Martínez-Yélamos A, Martínez-Yélamos S, Majós C.
    Eur Radiol; 2024 Feb 30; 34(2):1337-1345. PubMed ID: 37278854
    [Abstract] [Full Text] [Related]

  • 18. Age-related decline in cerebral oxygen consumption in multiple sclerosis.
    Knudsen MH, Vestergaard MB, Lindberg U, Simonsen HJ, Frederiksen JL, Cramer SP, Larsson HB.
    J Cereb Blood Flow Metab; 2024 Jun 30; 44(6):1039-1052. PubMed ID: 38190981
    [Abstract] [Full Text] [Related]

  • 19. Proton MR spectroscopy of lesion evolution in multiple sclerosis: Steady-state metabolism and its relationship to conventional imaging.
    Kirov II, Liu S, Tal A, Wu WE, Davitz MS, Babb JS, Rusinek H, Herbert J, Gonen O.
    Hum Brain Mapp; 2017 Aug 30; 38(8):4047-4063. PubMed ID: 28523763
    [Abstract] [Full Text] [Related]

  • 20. Cluster analysis of time evolution (CAT) for quantitative susceptibility mapping (QSM) and quantitative blood oxygen level-dependent magnitude (qBOLD)-based oxygen extraction fraction (OEF) and cerebral metabolic rate of oxygen (CMRO2 ) mapping.
    Cho J, Zhang S, Kee Y, Spincemaille P, Nguyen TD, Hubertus S, Gupta A, Wang Y.
    Magn Reson Med; 2020 Mar 30; 83(3):844-857. PubMed ID: 31502723
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.